India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
State Ba 302.00 3.18
I T C Lt 313.75 2.27
Sun Phar 623.30 0.60
Icici Ba 340.05 1.67
Tata Stl 580.60 2.20
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Dr Reddy`S Laboratories Limited
Dr Reddy`S Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:500124NSE:DRREDDYBloomberg:DRRD@INReuters:REDY.BO
Market Lot: 1Face Value: 5ISIN Demat: INE089A01023
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
26-Jul-2018       Dr Reddy'S Lab quarterly net soars 7.72 times  IRIS
26-Jul-2018       Dr. Reddy's Lab launches of Hervycta in India IRIS
16-Jul-2018       Dr Reddy's Lab to appeal decision of U.S. District Court IRIS
03-Jul-2018       Dr. Reddy's Laboratories launches Repatha in India IRIS
29-Jun-2018       Dr Reddy's Lab updates on patent litigation for Buprenorphine and Naloxone Sublingual Film IRIS
28-Jun-2018       Dr Reddy's Laboratories receives EIR for 2 facilities in Telangana IRIS
19-Jun-2018       Dr. Reddy's Lab launches Levetiracetam in NaCl injection IRIS
18-Jun-2018       Dr. Reddy's defends right to launch Buprenorphine and Naloxone Sublingual Film IRIS
15-Jun-2018       Dr. Reddy's receives nod for Buprenorphine, Naloxone Sublingual film IRIS
29-Mar-2018       Dr. Reddy's Laboratories announces senior leadership changes IRIS
19-Dec-2017       Dr Reddy's Labs reaches settlement with US Govt IRIS
12-Dec-2017       Dr. Reddy's Lab gets EIR from USFDA for Hyderabad facility IRIS
01-Dec-2017       Dr. Reddy's Lab gets first-cycle approval for Impoyz cream IRIS
21-Nov-2017       Dr. Reddy's receives EIR from USFDA for Vishakhapatnam facility IRIS
03-Nov-2017       Dr Reddy's launches generic Azacitidine for injection in Canada IRIS
03-Oct-2017       Dr. Reddy's Lab launches Sevelamer Carbonate tablets in US IRIS
22-Aug-2017       Dr Reddy's to get up to USD 32.5 mn milestone payments for DFD-06 IRIS
28-Jul-2017       Dr. Reddy's Lab enters into global licensing pact with CHD Bioscience IRIS
21-Jul-2017       USFDA completes audit at Dr. Reddy's API Cuernavaca plant in Mexico IRIS
19-Jun-2017       Dr. Reddy's receives USFDA observations for Srikakulam facility IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer